Share on PinterestScientists have found a gene that may explain the inherited risk of high cholesterol levels.Cholesterol has several vital functions in the human body. For instance, the molecule is a component of cell membranes, and the body needs it to make vitamin D and some hormones.However, excessive blood levels of cholesterol in the form…
Share on PinterestResearchers may have found an antibody to SARS-CoV-2, the virus that can cause COVID-19.A new study has identified an antibody that may be valuable in responding to the ongoing COVID-19 pandemic. The antibody has the potential to help treat the disease, as well as to reduce the chances of contracting the infection that…
live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.Coronaviruses are a family of viruses that comprise RNA enclosed within an envelope of protein and fat molecules. They commonly infect the respiratory and gastrointestinal tracts of their mammalian and bird hosts.The coronavirus that causes COVID-19, known…
Our European visitors are important to us. This site is currently unavailable to visitors from the European Economic Area while we work to ensure your data is protected in accordance with applicable EU laws.
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment